Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2: 48 Month Results from the Phase 1 Safety Trial.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_8E1103AC9B3D
Type
Inproceedings: an article in a conference proceedings.
Collection
Publications
Institution
Production externe
Title
Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2: 48 Month Results from the Phase 1 Safety Trial.
Title of the conference
ARVO Annual Meeting 2016, Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2038.
Author(s)
Clemons Traci E., Chew Emily Y., Peto Tunde, Sallo Ferenc B., Leung Irene
Publication state
Published
Issued date
01/05/2016
Peer-reviewed
Oui
Language
english
Create date
29/09/2024 19:33
Last modification date
30/09/2024 7:05
Usage data